Nuclear Medicine Radioisotopes Market by Product Type, Application, End-User - Global Forecast 2025-2030- Product Image

Sale

Nuclear Medicine Radioisotopes Market by Product Type, Application, End-User - Global Forecast 2025-2030

Report
186 Pages
October 2024
Region: Global
360iResearch™
ID: 5715987

UP TO €681EUR$697USD£568GBP OFF until Dec 31^st 2024

The Nuclear Medicine Radioisotopes Market grew from USD 10.46 billion in 2023 to USD 11.94 billion in 2024. It is expected to continue growing at a CAGR of 14.50%, reaching USD 27.00 billion by 2030.

Nuclear Medicine Radioisotopes form a pivotal part of modern diagnostic and therapeutic applications by utilizing small amounts of radioactive substances to diagnose, treat, and manage diseases, notably in oncology, cardiology, and neurology. The scope of this market encompasses radioisotopes such as Technetium-99m, Iodine-131, and Fluorine-18, critical for procedures like PET and SPECT scans. Their necessity is underscored by their ability to provide precise imaging and targeted therapy, enhancing diagnostic accuracy and treatment efficacy. As healthcare advances, the application of these isotopes is broadening, influencing sectors including hospital diagnostics, outpatient centers, and research institutions. Key growth factors include the aging global population, increasing prevalence of chronic diseases, and advancements in nuclear medicine technologies. Moreover, government initiatives and rising healthcare expenditure enhance the market’s expansion prospects. Among notable opportunities, the rise in theranostics - integrating therapeutic and diagnostic capabilities - offers a promising frontier for radioisotope utilization. However, challenges such as high production costs, stringent regulatory requirements, and short half-lives of isotopes hinder growth. Addressing supply chain issues, particularly the availability of production facilities and raw materials like molybdenum-99, remains crucial. Innovation in this field could focus on developing cost-effective production technologies, extending the shelf life of isotopes, and advancing hybrid imaging technologies. Enhanced collaboration between medical, scientific, and industrial stakeholders may drive breakthroughs in isotope production and application, with an emphasis on personalized medicine. The market, characterized by a steady demand yet faced with logistical and regulatory challenges, presents a robust landscape for innovation-driven growth. Companies that invest in R&D and align with evolving technological and regulatory trends are poised to capitalize on emerging opportunities.

Understanding Market Dynamics in the Nuclear Medicine Radioisotopes Market

The Nuclear Medicine Radioisotopes Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing need for SPECT, PET scan and nuclear medicine
- Remarkable growth of radiopharmaceutical drugs
- Increasing prevalence of cancer and cardiac disorders
Market Restraints
- Side effects with higher exposure
Market Opportunities
- Substantial growth of radiation therapy
- Emerging popularity of theranostics in nuclear medicine
Market Challenges
- Stringent government regulations

Exploring Porter’s Five Forces for the Nuclear Medicine Radioisotopes Market

Porter’s Five Forces framework further strengthens the insights of the Nuclear Medicine Radioisotopes Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Nuclear Medicine Radioisotopes Market

External macro-environmental factors deeply influence the performance of the Nuclear Medicine Radioisotopes Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Nuclear Medicine Radioisotopes Market

The Nuclear Medicine Radioisotopes Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Nuclear Medicine Radioisotopes Market

The Nuclear Medicine Radioisotopes Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Nuclear Medicine Radioisotopes Market

The Nuclear Medicine Radioisotopes Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Radioisotopes Market, highlighting leading vendors and their innovative profiles. These include Bruce Power Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, General Atomics Electromagnetic Systems, Grantek Systems, International Isotopes Inc., Medical Isotopes, Inc., NorthStar Medical Radioisotopes, LLC, Nuclear Research and consultancy Group, Ontario Power Generation Inc., Orano Group, ROSATOM State Atomic Energy Corporation, SHINE Technologies, LLC, SOFIE Co., and Urenco Stable Isotopes.

Market Segmentation & Coverage

This research report categorizes the Nuclear Medicine Radioisotopes Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Diagnostics
  - Fluorine-18
  - Gallium-67
  - Technetium-99
  - Thallium-201
- Therapeutic
  - Iodine-131
  - Rhenium-186
  - Samarium-153
  - Yttrium-90
Application
- Gastroenterology
- Neurology
- Oncology
- Orthopedics
End-User
- Diagnostic Centers
- Education & Research Institutes
- Hospitals
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing need for SPECT, PET scan and nuclear medicine
5.1.1.2. Remarkable growth of radiopharmaceutical drugs
5.1.1.3. Increasing prevalence of cancer and cardiac disorders
5.1.2. Restraints
5.1.2.1. Side effects with higher exposure
5.1.3. Opportunities
5.1.3.1. Substantial growth of radiation therapy
5.1.3.2. Emerging popularity of theranostics in nuclear medicine
5.1.4. Challenges
5.1.4.1. Stringent government regulations
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Nuclear Medicine Radioisotopes Market, by Product Type

6.1. Introduction
6.2. Diagnostics
6.2.1. Fluorine-18
6.2.2. Gallium-67
6.2.3. Technetium-99
6.2.4. Thallium-201
6.3. Therapeutic
6.3.1. Iodine-131
6.3.2. Rhenium-186
6.3.3. Samarium-153
6.3.4. Yttrium-90

7. Nuclear Medicine Radioisotopes Market, by Application

7.1. Introduction
7.2. Gastroenterology
7.3. Neurology
7.4. Oncology
7.5. Orthopedics

8. Nuclear Medicine Radioisotopes Market, by End-User

8.1. Introduction
8.2. Diagnostic Centers
8.3. Education & Research Institutes
8.4. Hospitals
8.5. Specialty Clinics

9. Americas Nuclear Medicine Radioisotopes Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Nuclear Medicine Radioisotopes Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Nuclear Medicine Radioisotopes Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET RESEARCH PROCESS
FIGURE 2. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NUCLEAR MEDICINE RADIOISOTOPES MARKET DYNAMICS
TABLE 7. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GALLIUM-67, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THALLIUM-201, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY IODINE-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY RHENIUM-186, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY EDUCATION & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 48. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 49. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 54. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 75. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 76. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 80. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 81. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 90. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 91. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 120. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 121. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 136. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 137. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 142. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 146. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 147. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 152. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 156. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 157. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 166. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 167. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 181. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 182. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 186. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 187. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 191. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 192. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 211. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 212. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 227. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 240. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Nuclear Medicine Radioisotopes Market, which are profiled in this report, include:

Bruce Power Inc.
Eckert & Ziegler Strahlen- und Medizintechnik AG
General Atomics Electromagnetic Systems
Grantek Systems
International Isotopes Inc.
Medical Isotopes, Inc.
NorthStar Medical Radioisotopes, LLC
Nuclear Research and consultancy Group
Ontario Power Generation Inc.
Orano Group
ROSATOM State Atomic Energy Corporation
SHINE Technologies, LLC
SOFIE Co.
Urenco Stable Isotopes

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	186
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 11.94 Billion
Forecasted Market Value ( USD ) by 2030	$ 27 Billion
Compound Annual Growth Rate	14.5%
Regions Covered	Global
No. of Companies Mentioned	14

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3464EUR$3,545USD£2,892GBP €3849EUR$3,939USD£3,213GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6128EUR$6,272USD£5,116GBP €6809EUR$6,969USD£5,684GBP

Understanding Market Dynamics in the Nuclear Medicine Radioisotopes Market

Exploring Porter’s Five Forces for the Nuclear Medicine Radioisotopes Market

Applying PESTLE Analysis to the Nuclear Medicine Radioisotopes Market

Analyzing Market Share in the Nuclear Medicine Radioisotopes Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Nuclear Medicine Radioisotopes Market

Strategic Recommendations for Success in the Nuclear Medicine Radioisotopes Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Nuclear Medicine Radioisotopes Market by Product, Application, End User, and Region 2024-2032

Nuclear Medicine Radioisotope - Global Strategic Business Report

Nuclear Medicine Radioisotopes Global Market Report 2024

Nuclear Medicine Radioisotopes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Nuclear Medicine Radioisotopes Market Report and Forecast 2024-2032

About the Nuclear Medicine Radioisotopes Market